[1]
M. A. Abbas, M. Z. Khan, H. M. Atif, A. Shahzad, and J. Mahar, “Computer-Aided Analysis of Oxino-bis-Pyrazolederivative as a Potential Breast Cancer Drug Based on DFT, Molecular Docking, and Pharmacokinetic Studies: Compared with the Standard Drug Tamoxifen”, IJBR, vol. 3, no. 6, pp. 535–537, Jun. 2025.